Overview
Status
Active
Registry date
2016-10-03
Share capital
5,000.00 PLN
Registered address
13, 38-607 Strzebowiska, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 446 days for 2019).
- 2025not filed
- 202418/09/2026
- 202329/08/2025
- 202223/07/2024
- 202109/06/2023
- 202005/01/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles26,508 / 42,239
Top 63%
Voivodeship · Podkarpackie7,508 / 16,359
Top 46%
Country · Poland224,533 / 495,850
Top 45%
Results vs industry
Revenue
This companyUSD 241.83kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 17.37kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 223.38kMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 108.92kMedianUSD 609.81kAverageUSD 11.84m
Industry
Authorized Representatives
Julia Anna Bieniasiewicz – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Julia Anna Bieniasiewiczage 41 | 95 | $1,283.09 | 95% |
Others | 5 | $67.53 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Panacea-Diagnostykasp. z o.o. | $270,780.69 | panacea.net.pl | ||
| PNN Pharmaceuticals sp. z o.o.sp. k. | $267,897.16 | pnn.com.pl | ||
| Aimedicalsp. z o.o. | $240,059.72 | aimedical.pl | ||
| Gierthsp. z o.o. | $240,006.46 | gierth.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Mitramed Paweł Wysocki, Piotr Wachaczyksp. j. | $198,282.96 | e.pl | ||
| Zdrowie Ze Znakiem Kangurasp. z o.o. | $177,221.20 | zdrowie-kangur.pl | ||
| Medicallenssp. z o.o. | $179,960.83 | medicallens.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| Pharmbiopolsp. z o.o. | $99,211.10 | pharmbiopol.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-07-07 | Address change (Ul. Piaskowa 40j/2, 31-341, Kraków → 13, 38-607, Strzebowiska) | |
| 2018-09-18 | Address change (Ul. Gen. Tadeusza Kościuszki 75/11, 30-114, Kraków → Ul. Piaskowa 40j/2, 31-341, Kraków) | |
| 2016-10-03 | Entered in the register |
FAQ
The main business activity of Colliq focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 3, 2016.
The headquarters is located at: 13, 38-607 Strzebowiska.
The management board consists of: Julia Anna Bieniasiewicz (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of USD 241,830 in 2024, which is an increase of 10.1% compared to 2023.
Yes, in 2024 the company achieved a net profit of USD 17,365.
The largest operating cost category falls under other operating costs. This category amounted to USD 100,547 in 2024, representing 45% of all operating expenses.
Last updated: 2026-09-18
